Mortality, morbidity, and asbestosis in New Zealand: The hidden legacy of asbestos exposure

New Zealand Medical Journal

Volumn 117, Issue 1205, 2004, Pages

  Smartt, Pamela ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASBESTOSIS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA ANALYSIS; DEATH CERTIFICATE; EPIDEMIC; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MESOTHELIOMA; MORBIDITY; MORTALITY; NEW ZEALAND; OCCUPATION; OCCUPATIONAL EXPOSURE; PNEUMOCONIOSIS; PREVALENCE; CARDIOVASCULAR DISEASE; ECONOMICS; HOSPITAL COST; LUNG TUMOR; MIDDLE AGED; RESPIRATORY TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ASBESTOSIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HOSPITAL COSTS; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; MORBIDITY; MORTALITY; NEW ZEALAND; OCCUPATIONS; RESPIRATORY TRACT DISEASES;

EID: 16644381660     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Mossman BT, Gee JB. Asbestos-related diseases. N Engl J Med. 1989; 320:1721-30.
2. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1666-80.
3. Churg A, Vedal S. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med. 1994;150:663-9.
4. Churg, A, Wright JL, Vedal S. Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. Am Rev Respir Dis. 1993; 148:25-31.
5. Anonymous, Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23:311-6.
6. Cooke WE. Pulmonary asbestosis. BMJ. 1927.2:1024-5.
7. Anonymous, Call for an international ban on asbestos. Scand J Work Environ Health. 1999;25:633-4.
8. Levin SM,. Kann PE, and Lax MB. Medical examination for asbestos-related disease. Am J Ind Med.. 2000;37:6-22.
9. Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955;12:81-6.
10. Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943-1976. Ann N Y Acad Sci. 1979;330:91-116.
11. Weiss W. Asbestosis: A marker for the increased risk of lung cancer among workers exposed to asbestos. Chest. 1999;115:536-49.
12. Berry G. Mortality of workers certified by pneumoconiosis medical panels as having asbestosis. Br J Ind Med. 1981;38:130-7.
13. Markowitz SB, Morabia A, Lilis R, et al. Clinical predictors of mortality from asbestosis in the North American Insulator Cohort, 1981 to 1991. Am J Respir Crit Care Med. 1997;156:101-8.
14. O'Reilly D, Reid J, Middleton R, Gavin AT. Asbestos related mortality in Northern Ireland: 1985-1994. J Public Health Med. 1999;21:95-101.
15. Occupational Safety and Health Service, National Asbestos Registers Annual Report 1997-98. Wellington. 1999; Department of Labour.
16. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345:535-9.
17. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997;145:211-18.
18. Kjellstrom T, Smartt P. Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started. N Z Med J. 2000;113:485-90.
19. Murin S, Bilello KS, Matthay R. Other smoking-affected pulmonary diseases. Clin Chest Med. 2000;21:121-37.
20. Bolton C, Richards A, Ebden P. Asbestos-related disease. Hosp Med. (London). 2002;63:148-51.
21. Occupational Safety and Health Service, Asbestos: Report of the Asbestos Advisory Committee to the Minister of Labour, April 1991. Wellington. 1991; Department of Labour.
22. Department of Health, Asbestos-related medical disorders. Therapeutic Notes No 212; 1991.
23. Anandanayagam LB, Rosairio S, Heaps AM, Low J. Compensation Issues for Asbestos related diseases. Fifth Year Medical Student Study, Department of Public Health, Wellington Medical School; 2000.
24. Glass W, Kawachi I, Pearce N. Lung cancer, smoking and exposure to asbestos in New Zealand. Journal of Occupational Health and Safety, Australia and New Zealand. 1991;7:43-7.
25. New Zealand Health Information Service, Mortality and Demographic Data. Wellington. Ministry of Health: Annual Reports for 1974-1999.
26. De Vos Irvine H, Lamont DW, Hole DJ, Gillis CR. Asbestos and lung cancer in Glasgow and the west of Scotland. BMJ. 1993;306:1503-06.
27. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191-308.
28. Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 1997;23:93-103.
29. Wilkinson P, Hansell DM, Janssens J, et al. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet. 1995;345:1074-8.
30. Frank AL. Public health significance of smoking-asbestos interactions. Ann N Y Acad Sci. 1979;330:791-4.
31. Churg A. Asbestos, asbestosis, and lung cancer. Mod Pathol. 1993;6:509-10.
32. Kilburn KH, Warshaw RH. Airways obstruction from asbestos exposure: Effects of asbestosis and smoking. Chest. 1994;106:1061-70.
33. Miller A. Pulmonary function in asbestosis and asbestos-related pleural disease. Environ Res. 1993;61:1-18.
34. Oksa P, Klockars M, Karjalainen A, et al. Progression of asbestosis predicts lung cancer. Chest. 1998;113:1517-21.
35. Wagner GR. Asbestosis and silicosis. Lancet. 1997;349:1311-5.
36. International Programme on Chemical Safety, Chrysotile asbestos. Environmental Health Criteria 203. 1998; Geneva (WHO 1998).
37. Albin M, Magnani C, Krstev S, et al. Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect. 1999;107:289-98.
38. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med. 1982;106:544-96.
39. Seidman H, Selikoff IJ, Hammond EC. Short-term asbestos work exposure and long-term observation. Ann N Y Acad Sci. 1979;330:61-89.
40. Wagner JC, Moncrieff CB, Coles R, et al. Correlation between fibre content of the lungs and disease in naval dockyard workers. Br J Ind Med. 1986;43:391-5.
41. NIOSH, The Work-Related Lung Disease Surveillance Report, 2002. Publication No. 111; 2003.
42. Coggon D, Inskip H, Winter P, Pannett B. Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis. Occup Environ Med. 1995;52:775-7.
43. Harber P, Smitherman J. Asbestosis: diagnostic dilution. J Occup Med. 1991;33:786-93.
44. American Thoracic Society. The diagnosis of nonmaliganant disease related to asbestos. Am Rev Respir Dis. 1986;134:363-8.